Basecamp Research Raises $140 Million for AI Designed Therapeutics
Sep 24, 2026
Funding
ABK Biomedical Raises $35 Million in Series D Funding Led by J.P. Morgan Life Sciences
Nov 12, 2025
ABK Biomedical has secured $35 million in an oversubscribed Series D funding round led by J.P. Morgan Life Sciences Private Capital, with participation from existing investors. The funds will support clinical operations, commercialization of Eye90 microspheres, and expansion of manufacturing capabilities.
ABK Biomedical has raised $35 million in an oversubscribed Series D financing round led by new investor J.P. Morgan Life Sciences Private Capital, announced in a press release. Existing investors including F-Prime, Santé Ventures, Eight Roads Ventures, and an undisclosed medical device company also participated.
The funds will support the company’s ongoing clinical operations, preparation for the commercialization of its Eye90 microspheres, and further product development. Additional capital will be used to expand manufacturing and supply chain capabilities to meet future demand.
Eye90 microspheres, which have received FDA Breakthrough Device Designation, are currently being evaluated in the Route90 FDA IDE pivotal trial. The company aims to use the proceeds to advance the trial and position the product for market readiness.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 KBRA Rated Anthropic BB+ Before $35 Billion Chip Financing Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer BankMore from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Sep 19, 2026
Funding
Axya Raises C$17 Million for AI Procurement Platform
Sep 24, 2026
Funding
Parakeet Health raises $10 million for AI patient access platform
Oct 01, 2026
Funding
Sensydia Raises More Than $6 Million for AI Cardiac System
Oct 13, 2026
Funding
Ambio raises €5.1 million for recycled plastics procurement platform
Oct 15, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.